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We read with interest the article by Yun et al. [1], who
reported that the frequency of diabetic retinopathy was
associated with the presence of arterial stiffness as
measured by the brachial ankle pulse wave velocity, but
not with common carotid artery intima-media thickness,
carotid plaque, or peripheral arterial disease (PAD), in a
Korean sample of type 2 diabetic patients. They
suggested that the association between macroangiopathy
and microangiopathy may be due to a functional rather
than structural process within the vascular system,
although arterial stiffness is widely accepted as a
structural phenomenon characterized by medial calcium
accumulation in the vessel wall.
Yun et al. [1] found no relation of PAD as diagnosed
by ankle brachial index (ABI) measurement to the
presence of retinopathy in their diabetic participants.
They successfully discussed this finding in light of the
previous studies that had displayed conflicting data with
respect to an association with microangiopathy and
clinical or subclinical atherosclerotic diseases. They also
linked their “negative condition” findings to several
factors such as selective survival, discordant sample
sizes in the tested groups, population characteristics,
image magnification limitations, or the age distributions
in their study population. At this point, we needed to
make some more contribution by going through the
diagnosis of PAD by ABI measurement in people with
diabetes mellitus.
Use of ABI measurement in the diagnosis of PAD in
subjects with diabetes, especially in those with long-
standing disease, requires caution with regard to recent
findings in large trials and recommendations inserted
into the guidelines. Diabetes has been linked not only to
accelerated atherosclerosis and plaque formation but also
to earlier initiation of arterial stiffness [2], as was also
shown in the study by Yun et al. [1]. However, it is well
known that arterial stiffness often causes inversely
increased ABI values due to incompressible vessels [3],
masking the presence of occlusive disease in the lower
extremities that could be identified by ABI testing.
Consistent with this, diabetes was clearly found to be a risk
factor for a high ABI [4]. Moreover, diabetic individuals
with ABI <0.90 and ABI >1.40 were demonstrated to
display similar patterns of abnormalities in different
diagnostic tests for lower extremity ischemia, and a high
ABI was suggested to be PAD-equivalent [4]. Therefore,
it is possible that the true prevalence of PAD might have
been underestimated by determining a low ABI in the
study by Yun et al. [1], resulting in insufficient statistical
power as well. Indeed, Table 1 of the study shows that
the frequency of PAD was detected to be 20.45% lower
in those subjects with retinopathy compared to those
without, which is not consistent with the knowledge that
the duration of diabetes is positively associated with the
prevalence of cardiovascular diseases. In order to
improve the understanding of our readers, it would be
helpful if the authors could re-evaluate their data for high
ABI (>1.4) or collectively with ABI 0.9 because,
Papanas et al. [5] reported a significantly higher
prevalence of a low ABI in diabetics with microvascular
complications when the subjects with medial arterial
calcification were specifically excluded.
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Author Response
We appreciate your excellent opinions after having
read the research article [1]. Our response to the thoughts
of the authors mentioned in the letter is as follows.
Ankle-brachial index (ABI) is a convenient and simple
method of measuring peripheral arterial disease (PAD) in
clinical examination and research. The ABI measurement
method has been introduced and been enforced since the
1960s, and a decrease in ABI (<0.9) has been applied as
a powerful indicator of PAD diagnosis. The severity of
PAD is generally classified as normal (0.91-1.30), mild
occlusion (0.70-0.90), moderate occlusion (0.40-0.69),
severe occlusion (<0.40), or poorly compressive vessels
(>1.30).
Diabetes induces not only structural changes (i.e.,
increased intima-media thickness, plaque formation) but
also arterial stiffness. Just as you have said, when one
tries to measure ABI in the state of arterial stiffness, ABI
is measured as higher than expected due to improper
vessel compression. Because diabetes and medial artery
calcification have a strong association [2], ABI results
come out to be higher than expected because ankle
pressure rises due to arterial stiffness. Therefore, PAD
(defined as ABI <0.9) that is calculated by measuring
ABI can show a much lower prevalence rate than the
reality. In particular, there have been reports that
asserted, in the case where a patient has peripheral
neuropathy related to diabetes, PAD diagnostic
efficiency by ABI measurement decreases [3]. Recently,
when defining the PAD of diabetic patients, some
epidemiologic studies have claimed that one should
include a high ABI group of not only ‘ABI <0.9’ but
also ‘ABI >1.40’ [4,5].
Yun et al. [1] reported the results of having defined
PAD as ‘ABI <0.9.’ The difference in the PAD
prevalence rate between subjects with retinopathy and
without retinopathy (10.6% vs. 8.8%) was not
significant. Also, no significant association between
PAD and retinopathy (odds ratio, 0.77; 95% confidence
interval, 0.34 to 1.73) was found. After that, in addition
to the analysis of PAD, just as you have suggested in the
letter, additional analysis of ‘high ABI (>1.40)’ and of
‘PAD equivalent (ABI <0.9 or >1.4)’ were done.
However, no significant association was observed in any
of these studies (Tables 1 and 2). In addition, ‘high ABI’
and ‘PAD equivalent’ were re-classified and analyzed
based on an ABI of 1.3 as a standard, but the result was
similar to the case where an ABI of 1.4 was set as the
standard. Findings such as these, just as suggested in the
existing report [1], are assumed to be the result of
selective survival, discordant sample sizes, population
characteristics, image magnification limitations, certain
age distributions, and so on.
It is necessary to analyze and interpret the ABI
measured from a diabetic patient very carefully in
consideration of clinical symptoms, and it is necessary to
diagnose PAD while keeping in mind the limitations of
ABI measurement of diabetic patients, and by utilizing
other noninvasive examination methods. Furthermore, it
will be important to clarify the association between
retinopathy and PAD of diabetic patients through
additional research in the future.
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Table 1. PAD, high ABI, and PAD equivalent pre-
valence of study group with and without retinopathy
Variables
Without
retinopathy
(n=491)
With
retinopathy
(n=114)
p-
value
PAD (ABI <0.9)
High ABI (ABI >1.4)
PAD equivalent (ABI <0.9 or >1.4)
52 (10.6)
4 (0.8)0
55 (11.2)
10 (8.8)0
2 (1.8)0
12 (10.5)
0.56
0.36
0.84
Values are presented as number (%).
PAD, peripheral arterial disease; ABI, ankle-brachial index.
Table 2. OR for diabetic retinopathy according to ABI level
Variables Crude OR (95% CI) Model 1
1 OR (95% CI) Model 2
2 OR (95% CI)
PAD (ABI <0.9)
High ABI (ABI >1.4)
PAD equivalent (ABI <0.9 or >1.4)
0.81 (0.40, 1.65)
2.17 (0.39, 12.02)
0.93 (0.48, 1.81)
1.01 (0.49, 2.10)
2.01 (0.35, 11.49)
1.13 (0.57, 2.24)
0.77 (0.34, 1.73)
2.23 (0.32, 15.73)
0.89 (0.42, 1.91)
OR, odds ratio; ABI, ankle-brachial index; CI, confidence interval; PAD, peripheral arterial disease.
1 Adjusted for age and sex.
2 Adjusted for age, sex, duration of diabetes, HbA1c, total cholesterol, log-transformed triglycerides, high-density lipoprotein cholesterol, estimated glomerular
filtration rate, body mass index, and history of hypertension.